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Abstract
Objective To study the correlation between a dynamic
index of cerebral autoregulation assessed with blood flow
velocity (FV) using transcranial Doppler, and a tissue
oxygenation index (TOI) recorded with near-infrared
spectroscopy (NIRS).
Methods Twenty-three patients with sepsis, severe sepsis,
or septic shock were monitored daily on up to four con-
secutive days. FV, TOI, and mean arterial blood pressure
(ABP) were recorded for 60 min every day. An index of
autoregulation (Mx) was calculated as the moving corre-
lation coefficient between 10-s averaged values of FV and
ABP over moving 5 min time-windows. The index Tox
was evaluated as the correlation coefficient between TOI
and ABP in the same way. The indices Mx and Tox, ABP
and arterial partial pressure of CO2 were averaged for each
patient.
Results Synchronized slow waves, presenting with peri-
ods from 20 s to 2 min, were seen in the TOI and FV of
most patients, with a reasonable coherence between the
signals in this bandwidth (coherence >0.5). The indices,
Mx and Tox, demonstrated good correlation with each
other (R = 0.81; P < 0.0001) in the whole group of
patients. Both indices showed a significant (P < 0.05)
tendency to indicate weaker autoregulation in the state of
vasodilatation associated with greater values of arterial
partial pressure of CO2 or lower values of ABP.
Conclusion NIRS shows promise for the continuous
assessment of cerebral autoregulation in adults.
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Abbreviations
ABP Mean arterial blood pressure
CBF Cerebral blood flow
FV Mean blood flow velocity
Mx Mean flow velocity index of dynamic
autoregulation
NIRS Near-infrared spectroscopy
PaCO2 Arterial blood partial pressure of carbon dioxide
TCD Transcranial Doppler
TOI Tissue oxygenation index
Tox Tissue oxygenation index of dynamic
autoregulation
Cerebral near-infrared spectroscopy (NIRS) is an evolving
technology [1]. The rationale of using NIRS to monitor
cerebral autoregulation is based on the assumption that the
brain’s oxygen content is positively related to arterial
oxygen saturation, cerebral blood flow (CBF), and oxygen-
tissue diffusivity, and negatively associated with the cere-
bral metabolic rate for oxygen. Comparisons of changes in
tissue oxygenation over short periods of time (3–6 min),
taking place in response to changes in arterial pressure,
with presumed stable arterial saturation, stable metabolism,
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and probably stable diffusivity, should give similar infor-
mation as a comparison of changes in CBF and arterial
pressure. The advantage of such a setup for clinical mon-
itoring is potentially immense: NIRS is non-invasive, does
not require frequent calibration, is fairly robust, and con-
trary to transcranial Doppler (TCD), the problem of a
constant and precise location of the probes is not an issue.
However, the use of NIRS to monitor cerebral autoregu-
lation in adults is still debatable. In contrast to neonates,
thick skulls and large head circumferences do not allow for
full trans-cerebral measurements. Instead a hemispheric
approach is used resulting in a sample volume that is not
defined.
Newer apparatus, such as the INVOSTM cerebral oxy-
meter (Somanetics Corporation, Troy, Michigan, USA) or
the NIRO 300 or 200 (Hamamatsu Photonics, Hamamatsu
City, Japan) are supposed to attenuate the influence of the
extracranial circulation. This is achieved by resolving
spatial differences between three emitting and detecting
diodes separated by different distances. The proportion of
oxygenated and deoxygenated hemoglobin is calculated
not from one pair of absolute values but from the regres-
sion line between values from the three detectors. In this
way, a tissue oxygenation index is calculated, which is
supposed to replicate brain oxygen saturation [2]. Using the
NIRO 300 in the controlled environment of carotid end-
arterectomy, it has been demonstrated that the tissue
oxygenation index (TOI) is sensitive to changes in hemi-
spheric, intracerebral blood supply and is little affected by
extracranial contamination [3]. The TOI has also been
shown to be independent of hemoglobin concentration,
skull thickness, and the area of the cerebrospinal fluid layer
underlying the optodes [4].
The use of NIRS to evaluate cerebrovascular reactivity
to changes in PaCO2 in adults was discussed in 1995 [5].
More recently, it was shown that in adults stable 0.1 Hz
oscillations of hemodynamic parameters induced by regu-
lar breathing at a rate of 6/min, bring about cortical
hemodynamic responses that follow specific phase rela-
tionships due to cerebral autoregulatory action and
circulatory transit times which can be measured by NIRS
[6]. With hemodynamic impairment, as in unilateral carotid
obstruction, these phases were significantly changed
reflecting disturbed autoregulation. The correlation
between changes in cerebral perfusion pressure and a
cerebral tissue oxygenation index over time was demon-
strated to correlate with cerebral autoregulation assessed
using laser Doppler cortical blood flow during experi-
mental intracranial hypotension in piglets [7]. A similar
technique proved to be promising in neonates [8].
Cerebral autoregulation is increasingly being recognized
as a potentially interesting monitoring parameter in neur-
ocritical care. Disturbed autoregulation has been shown to
be associated with unfavorable outcome after head injury
[9], vasospasm after subarachnoid hemorrhage [10], and
the possibility to use autoregulation to define an individual
target for cerebral perfusion pressure is suggested (rec-
ommendation, level III) in the latest edition of the Brain
Trauma Foundation Guidelines for the management of
severe traumatic brain injury [11].
We compared a validated TCD index of autoregulation
(Mx) [9] with a measure of autoregulation utilizing the TOI
in a group of patients suffering from sepsis, severe sepsis,
or septic shock.
Methods
Data were prospectively collected during a clinical study
focusing on septic encephalopathy in the medical and
surgical intensive care units of the University Hospital
of Basel, Switzerland (www.clinicaltrials.gov Identifier
NCT00410111). The protocol was approved by the Regional
Ethical Committee and written consent was obtained from
all patients or their next of kin. The main aim of the clinical
study was to investigate various indices of cerebral perfu-
sion and metabolism as markers of delirium in sepsis [12].
As a part of the measurement protocol we studied the
relationship between Mx [9] and dynamic changes of cere-
bral tissue oxygenation measured using the TOI provided by
a NIRO 200 monitor (Hamamatsu Photonics, Solothurn,
Switzerland). Inclusion criteria were age >18 years and
sepsis, severe sepsis, or septic shock without an intracranial
focus of infection. Patients with a history of cerebrovascular
or intracranial neurological disease were excluded.
Mean arterial blood pressure (ABP) was measured
directly from the radial or femoral artery. Patients were
monitored for 1 h every day on up to four consecutive
days, depending on their length of stay in the intensive care
unit or survival. NIRS measurements were performed
bilaterally over the frontal to frontoparietal area. Blood
flow velocity (FV) in the middle cerebral artery of both
hemispheres was monitored concurrently using TCD with a
2-MHz probe (Multidop T, DWL, Germany). Analogue
outputs from direct arterial pressure monitoring, and TCD
and digital NIRS data (1 Hz) from the serial output of the
NIRO 200 were transferred to a laptop computer via an
analogue-to-digital converter where necessary and were
processed using the ‘‘ICM+ software’’, version 6.1, from
the University of Cambridge, UK [13].
Information regarding cerebral autoregulation is inclu-
ded in so-called slow (20 s–3 min) vasocycling of cerebral
blood flow [9]. In a first step the coherence function
between FV and TOI signals was analyzed. Absolute val-
ues of the coherence function (see Fig. 1) indicate the
distribution of the ‘correlation coefficients’ of the
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components of both signals in different frequency ranges.
High values (close to +1) indicate that both signals contain
components of high correlation. If changes in FV (pro-
portional to changes in CBF) are useful for the assessment
of cerebral autoregulation, and high values for coherence
are found, similar information is included in TOI.
Cerebrovascular autoregulation was assessed by calcu-
lating Mx as a correlation coefficient between 30 10 s
averages of ABP and FV signals [9, 14]. Accordingly, Mx
was calculated from a 5 min time-window, and this win-
dow was moved every 60 s. A positive Mx value indicates
impaired autoregulation, and a zero or negative correlation
coefficient intact autoregulation (see Fig. 2). The Mx index
has previously been validated by comparison to the static
rate of autoregulation [15], the transient hyperemic
response test [16], the leg-cuff test of cerebral autoregu-
lation [14], the autoregulation index ARI [17], the
pressure-reactivity index PRx [18], the phase shift between
slow waves of FV and ABP [19], and the CO2 reactivity
test [20]. Using the same principle, a moving correlation
coefficient between 10 s averages of ABP and TOI signals
(Tox) was calculated. A similar index, using the INVOSTM
cerebral oxymeter, was validated in piglets using laser
Doppler flowmetry and cerebral perfusion pressure mea-
surements during graded hypotension experiments [7].
Values from the right and left hemisphere from TCD and
NIRS were averaged for analysis. In this group of patients,
without a history of cerebrovascular disease, this will not
introduce a bias.
Time-averaged values from every examination (average
period of monitoring of 60 min) were used for analysis.
Analysis of variability of autoregulation indices was per-
formed using individual examinations (n = 81). Comparisons
between Mx, Tox, ABP, and arterial partial pressure of CO2
(PaCO2) were performed between averaged values of all daily
measurements performed in each patient (n = 23). SPSS 15.0
for Windows (SPSS Inc., Chicago, Illinois, USA) was used to
analyze the data.
Results
Mean patient age (SD) was 68 [18], 39% were women.
Mean APACHE II Score was 22 [7]. Thirteen patients
suffered from pneumonia, eight from intra-abdominal
infections, and one patient each from soft tissue and joint
infection. Fifteen patients needed norepinephrine for sta-
bilization of arterial blood pressure, six patients received
dobutamine in addition to norepinephrine. No patient
received antihypertensive drugs.
For each raw data file (representing 60 min of recording;
n = 81) time trends of 10 s averages of TOI and FV both
revealed the presence of variable intensity slow waves with
periods ranging from 20 s to 2 min. Coherence analysis
indicated a good level of association between the two
trends (value >0.5) in a frequency band from 0.5 to 3
cycles/min (Fig. 1). This finding suggests that both FV and
TOI signals contain similar slow waves, potentially car-
rying information on cerebral autoregulation.
Individual recordings revealed the same slow wave
character for the relationship between FV and ABP (Mx),
and between TOI and ABP (Tox) in cases of defective
Fig. 1 Slow waves of flow
velocity (FV) measured with
transcranial Doppler and of a
tissue oxygenation index (TOI)
measured with near-infrared
spectroscopy (NIRS). Both
signals were moving-averaged
with a time window of 10 s. The
bottom graph shows a high
coherence between waves in the
0.5–3 cycles/min frequency
band equivalent to periods of
20 s–2 min. High coherence
indicates that slow waves
detected by TCD and NIRS in
this frequency band are similar;
therefore, NIRS may have a
potential use for dynamic
autoregulation assessment
similar to the well-established
use of TCD
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(Fig. 2a), and functional (Fig. 2b) autoregulation. Overall,
the regression between Tox and Mx in this group of 23
patients showed a strong positive association between the
two indices (R = 0.81; P < 0.0001, Fig. 3). The regres-
sion model for the prediction of Mx using Tox is as
follows: Mx = 0.14 + 1.53 Tox. The bias for the model
(mean value of residuals) was 0.0002 with a standard
deviation of 0.17. The 95% confidence limits for the pre-
diction of Mx using Tox were ±0.34.
Both indices were related to the PaCO2 (Mx: R = 0.43;
P < 0.03 and Tox: R = 0.49; P < 0.02; n = 23),
indicating that PaCO2-induced dilatation of flow-regulating
vessels was associated with worse autoregulation.
Similarly, there was a strong correlation between Mx
and ABP (R = -0.65; P < 0.001; n = 23) and between
Tox and ABP (R = -0.57; P < 0.005; n = 23). These
relationships indicate that at lower arterial pressures dis-
turbance of autoregulation is more likely to happen, due to
a potentially shorter distance to the lower limit of
autoregulation.
Day-to-day variations of autoregulation are likely to
exist and may reflect changes in the clinical status, PaCO2,
Fig. 2 (a) Example of passive
transmission between slow
waves of mean arterial blood
pressure (ABP), a tissue
oxygenation index (TOI)
measured with near-infrared
spectroscopy, and flow velocity
(FV) measured with transcranial
Doppler with a positive value of
the index of autoregulation Tox
(upper panel). The same
regression between ABP and
Mx produces a positive index
Mx (lower panel). This pattern
is specific for disturbed
autoregulation. (b) Example of
active regulation of CBF which
produces a negative correlation
between ABP and TOI (Tox is
negative, upper panel). The
correlation between ABP and
FV is also negative (lower
panel)
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ABP, etc.—see example in Fig. 4. The average standard
deviation of Tox within patients was 0.17 as compared to
standard deviation between patients of 0.11. The range of
within-patient variations was 0.029–0.27.
Discussion
Slow, synchronized waves of periods from 20 s to 2 min,
as seen in FV, and traditionally used for the assessment of
cerebral dynamic autoregulation using various models [9,
21–23], can also be observed in NIRS-derived TOI.
Interestingly, such slow waves are usually not observed in
directly measured brain tissue oxygenation. This may be
due to the fact that NIRS-derived TOI mainly reflects
oxygenation in cerebral venous blood, whereas direct
methods reflect oxygenation in brain tissue. Diffusivity of
oxygen from blood to tissue may delay the fast fluctuations
of TOI, evidently related to vasomotion-induced accelera-
tion and deceleration of CBF. Similarly, changes in TOI
related to fluctuations in brain metabolism are probably
much slower and, without stimulation, may rarely happen
in repetitive fashion, particularly in sedated patients.
Therefore, Tox may be much more precise in the assess-
ment of autoregulation, than an index of oxygen reactivity
derived from changes in direct brain tissue oxygen content
and cerebral perfusion pressure [24].
The phenomenon of fluctuations of TOI, synchronous
with slow waves in FV, may open new perspectives for the
continuous non-invasive monitoring of cerebral autoregu-
lation using NIRS. Such a possibility was explored
previously [6, 25–27], but in the present study, the meth-
odology was used consistently for the first time in a clinical
trial in adults. We demonstrate a surprisingly good corre-
lation between the established Mx index of autoregulation
[9, 15, 20] and this new NIRS-based index, Tox. Both
indices react to PaCO2-induced vasodilatation, demon-
strating a worsening of cerebral autoregulation. Also, both
seem to react to arterial hypotension, indicating a gradual
decrease of autoregulatory reserve. However, unlike TCD
probes, the optodes of modern NIRS devices can be fixed
on the forehead of patients using double-sided stickers,
thus avoiding the problem of probe dislocation which
seriously limits the quality of long-term TCD recordings.
Furthermore, loss of signal during longer recordings due to
drying of the jelly used with TCD is also not an issue.
Finally, potential small displacements of the optodes over
longer periods will not disturb the quality of monitored
Fig. 3 Regression between averaged values of Tox and Mx in 23
patients suffering from sepsis, severe sepsis, or septic shock indicates
a good correlation between these two modalities
Fig. 4 Example of rapid
worsening of cerebral
autoregulation in response to
spontaneous arterial
hypotension. Flow velocity
(FV) and the tissue oxygenation
index (TOI) decrease around
12:05, and the indices Tox and
Mx both increase toward values
close to +1
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variables as heavily as movement of TCD probes. On the
other hand, NIRS measurements are susceptible to ambient
light and shielding of the optodes is necessary.
Tox is, as Mx, a dimensionless index, which makes it
ideal for comparisons between patients. Positive values
around +1 indicate disturbed autoregulation, and values
around zero and negative values good autoregulation.
Negative values of Mx are interpreted as a reflection of the
negative slope of the CBF-ABP curve, often seen just
above the lower limit of autoregulation, particularly with
hypocapnia. This is, most probably, also the case with the
index Tox. The index Mx is used as a continuous descriptor
of autoregulatory reserve. Using any threshold values for
Mx is difficult due to the fact that autoregulation derived
from FV in the middle cerebral artery is not necessarily
representative for the whole brain, and in pathology,
autoregulation may be patchy even within the territory of
the middle cerebral artery. For clinical convenience, in
head injured patients Mx greater than 0.5 indicates defi-
nitely disturbed autoregulation which translates to a value
above 0.3 for the index assessed using cerebral perfusion
pressure rather than arterial pressure alone [28]. From the
regression formula, critical values for Tox should be set
between 0.2 and 0.3. Obviously, like Mx and other meth-
ods used for continuous analysis of autoregulation, Tox
should be verified for different pathologies and in healthy
volunteers. If verified, it could become a powerful tool to
facilitate brain monitoring in clinical neurosciences.
Limitations
Possible limitations of the study are the small number of
patients, the selected patient population, the indirect evalu-
ation of Tox based on Mx rather than on a direct evaluation
using, e.g. CO2 reactivity or a standardized blood pressure
change. In this observational study blood pressure was not
challenged. Spontaneous changes of ABP (slow fluctuations
of periods from 2 min to 20 s) were used instead. Similarly,
spontaneous differences in PaCO2, resulting from different
respiratory regimes were used for analysis. PaCO2 was
monitored using arterial blood gas analysis. We did not
include a control group of healthy volunteers to compare Tox
and Mx. A correlation between a new index of autoregulation
(Tox) and Mx, an established index of autoregulation [9, 15,
19–22] requires comparisons of the variables across a group
of patients with both good and disturbed autoregulation.
Patients with sepsis are ideal for this purpose, as they have a
large spectrum of autoregulatory depletion. Moreover, a
comparison of volunteers to medicated, ventilated patients
may be misleading. This has been partially discussed previ-
ously [29]. Both Tox and Mx show rapid variations which
may be caused by changes in the intensity of useful
components for the assessment of autoregulation (slow
waves) or fast changes in the strength of dynamic regulation
(see example in Fig. 4). A reasonable time of averaging
(minimum of 30 min) is necessary to achieve reliable results.
Conclusion
Vasocycling, i.e. waves of periods from 20 s to 2 min seen
in cerebral blood flow velocity can be also recorded in the
NIRS-derived tissue oxygenation index, TOI. Indices of
dynamic autoregulation assessed using NIRS and TCD are
in agreement in adults with sepsis.
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